Scrutinizing the Biomarkers for the Neglected Chagas Disease: How Remarkable!
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Scrutinizing the Biomarkers for the Neglected Chagas Disease: How Remarkable!
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-08-11
DOI
10.3389/fimmu.2016.00306
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease
- (2015) S.M. Keating et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cruzipain Activates Latent TGF-β from Host Cells during T. cruzi Invasion
- (2015) Patrícia Mello Ferrão et al. PLoS One
- Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3highregulatory T cells in humans
- (2015) Makoto Miyara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aptamer-Based Detection of Disease Biomarkers in Mouse Models for Chagas Drug Discovery
- (2015) Fernanda Fortes de Araujo et al. PLoS Neglected Tropical Diseases
- Immunity and immune modulation inTrypanosoma cruziinfection
- (2015) Fabíola Cardillo et al. Pathogens and Disease
- Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment
- (2014) Cynthia Santamaria et al. BMC INFECTIOUS DISEASES
- Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review
- (2014) Maria-Jesús Pinazo et al. Expert Review of Anti-Infective Therapy
- MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in Chronic Chagas disease Cardiomyopathy
- (2014) Ludmila Rodrigues Pinto Ferreira et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Plasma Cytokine Expression Is Associated with Cardiac Morbidity in Chagas Disease
- (2014) Giovane Rodrigo Sousa et al. PLoS One
- Aptamer Based, Non-PCR, Non-Serological Detection of Chagas Disease Biomarkers in Trypanosoma cruzi Infected Mice
- (2014) Rana Nagarkatti et al. PLoS Neglected Tropical Diseases
- Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways
- (2013) Amanda Farage Frade et al. BMC INFECTIOUS DISEASES
- Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review
- (2013) Ana Requena-Méndez et al. Expert Review of Anti-Infective Therapy
- Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy
- (2013) Juliana F. Vasconcelos et al. FASEB JOURNAL
- Matrix Metalloproteinases 2 and 9 Are Differentially Expressed in Patients with Indeterminate and Cardiac Clinical Forms of Chagas Disease
- (2013) Rafaelle Christine Gomes Fares et al. INFECTION AND IMMUNITY
- Predictive value of transforming growth factor-β1in Chagas disease: towards a biomarker surrogate of clinical outcome
- (2013) Roberto M Saraiva et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Cell Death and Serum Markers of Collagen Metabolism during Cardiac Remodeling in Cavia porcellus Experimentally Infected with Trypanosoma cruzi
- (2013) Yagahira E. Castro-Sesquen et al. PLoS Neglected Tropical Diseases
- The TGF-β Pathway as an Emerging Target for Chagas Disease Therapy
- (2012) T C Araújo-Jorge et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Deficient Regulatory T Cell Activity and Low Frequency of IL-17-Producing T Cells Correlate with the Extent of Cardiomyopathy in Human Chagas' Disease
- (2012) Paulo Marcos Matta Guedes et al. PLoS Neglected Tropical Diseases
- Oral Administration of GW788388, an Inhibitor of Transforming Growth Factor Beta Signaling, Prevents Heart Fibrosis in Chagas Disease
- (2012) Fabiane L. de Oliveira et al. PLoS Neglected Tropical Diseases
- Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease
- (2011) G.A. DosReis BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Immunoneuroendocrine alterations in patients with progressive forms of chronic Chagas disease
- (2011) A.R. Pérez et al. JOURNAL OF NEUROIMMUNOLOGY
- Regulatory T Cells Phenotype in Different Clinical Forms of Chagas' Disease
- (2011) Fernanda Fortes de Araújo et al. PLoS Neglected Tropical Diseases
- Gene Expression Changes Associated with Myocarditis and Fibrosis in Hearts of Mice with Chronic Chagasic Cardiomyopathy
- (2010) Milena Botelho Pereira Soares et al. JOURNAL OF INFECTIOUS DISEASES
- Gap junction reduction in cardiomyocytes following transforming growth factor-β treatment and Trypanosoma cruzi infection
- (2010) Mariana C Waghabi et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Diagnosis, management and treatment of chronic Chagas’ gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemic
- (2009) María Jesús Pinazo et al. Gastroenterologia y Hepatologia
- Plasma ACE2 Activity is an Independent Prognostic Marker in Chagas' Disease and Equally Potent as BNP
- (2009) Yong Wang et al. JOURNAL OF CARDIAC FAILURE
- Pivotal role for TGF-β in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy
- (2008) Tania C. Araújo-Jorge et al. CYTOKINE & GROWTH FACTOR REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started